Unizin

Unizima is a global provider of biomanufacturing solutions and a subsidiary of the Univercells Group. The company focuses on increasing the accessibility of biologics and vaccines in emerging markets by providing end-to-end bioproduction services, including facility design, technology transfer, and operational support. Utilizing Univercells' proprietary NevoLine and Scale-X platforms, Unizima enables cost-effective, high-yield manufacturing of complex therapeutics such as monoclonal antibodies and viral vectors. Their business model centers on empowering local production capabilities to address global health disparities and ensure a sustainable supply of essential medicines.